Fennec Pharmaceuticals Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $427.0K | $3.3M | $3.3M |
| Jun 2017 | $580.0K | $10.3M | $10.2M |
| Sep 2017 | $1.0M | $9.9M | $9.7M |
| Dec 2017 | $1.6M | $28.4M | $28.3M |
| Mar 2018 | $1.2M | $26.8M | $26.7M |
| Jun 2018 | $847.0K | $25.7M | $25.6M |
| Sep 2018 | $2.1M | — | $24.5M |
| Dec 2018 | $1.6M | $23.0M | $22.8M |
| Mar 2019 | $1.5M | $20.7M | $20.2M |
| Jun 2019 | $1.4M | $17.8M | $13.7M |
| Sep 2019 | $905.0K | $15.9M | $15.2M |
| Dec 2019 | $2.3M | $14.1M | $13.7M |
| Mar 2020 | $1.9M | $10.4M | $9.9M |
| Jun 2020 | $3.2M | $39.3M | $38.7M |
| Sep 2020 | $2.9M | $34.1M | $33.2M |
| Dec 2020 | $2.3M | $31.4M | $30.3M |
| Mar 2021 | $2.9M | $27.8M | $26.8M |
| Jun 2021 | $5.8M | $28.1M | $27.3M |
| Sep 2021 | $7.0M | $26.0M | $24.3M |
| Dec 2021 | $6.6M | $22.4M | $21.1M |
| Mar 2022 | $6.6M | $19.1M | $18.3M |
| Jun 2022 | $7.0M | $15.6M | $14.9M |
| Sep 2022 | $27.6M | $30.4M | $29.8M |
| Dec 2022 | $29.5M | $26.9M | $23.8M |
| Mar 2023 | $29.2M | $21.8M | $18.4M |
| Jun 2023 | $29.2M | $19.4M | $15.0M |
| Sep 2023 | $29.6M | $20.0M | $12.4M |
| Dec 2023 | $38.5M | $26.9M | $13.3M |
| Mar 2024 | $66.2M | $69.2M | $51.2M |
| Jun 2024 | $64.5M | $63.2M | $43.1M |
| Sep 2024 | $64.1M | $58.9M | $40.3M |
| Dec 2024 | $50.8M | $44.9M | $26.6M |
| Mar 2025 | $52.3M | $46.4M | $22.7M |
| Jun 2025 | $52.3M | $44.9M | $18.7M |
| Sep 2025 | $53.8M | $49.3M | $21.9M |
| Dec 2025 | $35.1M | $70.6M | $36.8M |
| Mar 2026 | $34.1M | $71.8M | $40.2M |
| Jun 2026 | $33.3M | $75.8M | $41.2M |